India Proposes OTC List In Draft Rule Lacking Clarity On Pricing, Switching Pathway
Executive Summary
India puts out rules for first set of over-the-counter drugs but provides no specifics on the pricing policy for such products or the wider switching pathway. Can the framework foster responsible self-medication and help reap value for patients in a market where the oversight of trade channels for sale of prescription-based drugs is lax?